Chemogenetics (DREADDs)
Chemogenetics is a method for turning chosen brain cells up or down by giving an animal a harmless pill or injection. Researchers first insert into a selected group of neurons the gene for an engineered receptor — a protein that sits in the cell's surface like a tiny lock. This lock has been altered so that the body's own chemicals no longer fit it, and only a special designer drug, otherwise inert, can turn the key. The best-known versions are called DREADDs, short for designer receptors exclusively activated by designer drugs.
Once those neurons carry the engineered receptor, the rest is simple. When the matching drug reaches the brain through the bloodstream, it docks onto the lock and switches the cell's behavior in a chosen direction — one flavor of receptor makes the targeted neurons more likely to fire, another quiets them down, by tuning the chemical messengers the cell uses inside itself. Because only the genetically marked cells carry the lock, the drug sweeps through the whole brain yet acts on those cells alone.
The trade-off compared with light-based control is speed versus reach. A drug takes minutes to act and its effect lasts hours, so chemogenetics is suited to chronic, long-lasting nudges rather than millisecond switching — but it needs no implanted fiber or wire and can hold an entire scattered population on or off while an animal moves and behaves freely. This makes it a favored tool for asking what a defined set of neurons contributes to behavior over the span of a whole experiment.
Hours after a single injection of the designer drug, a mouse's anxiety neurons stay quietly switched off, and the animal explores an open arena it would normally avoid.
One drug, hours of control — a whole population of cells held off while the animal behaves freely.
Chemogenetics and optogenetics are siblings: both reach a genetically chosen set of cells, but light gives millisecond precision through a fiber, while a designer drug acts slowly and brain-wide with no implant.